📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

WILL SGLT2 INHIBITORS PROVE TO BE A 'MULTIPLE' GAMECHANGER? (2019)

First Author: Sharkey N

Attributed to: Integrative genomic, epigenetic and functional studies in diabetic kidney disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 30675070

Publication URI: http://europepmc.org/abstract/MED/30675070

Type: Journal Article/Review

Volume: 88

Parent Publication: The Ulster medical journal

Issue: 1

ISSN: 0041-6193